Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
venerdì, ottobre 23
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Mangoceuticals Inc
MGRX
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$0.2318
-0.0125
-5.12%
Ult. Agg.: Oct 23, 6:00 PM
Get Report
Panoramica
Notizie
Previsioni utili
Dati finanziari
Sentiment
Azionariato
Confronta
Rapporto azionario
Mangoceuticals Financials
Mangoceuticals (MGRX) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Stock Market Today: S&P 500, Dow Jones Futures Gain as Investors Await September's Jobs Report Data — NKE, SYNA, CTVA in Focus
U.S. stock futures advanced on Friday, as the Dow Jones, S&P 500 and Nasdaq 100 indices rose, following Thursday's higher close.
Rishabh Mishra
Nike, Synaptics And 3 Stocks To Watch Heading Into Friday
Nike falls on weak revenue; Synaptics jumps on $123 ON deal; AsiaStrategy surges on tokenization pact; Mangoceuticals drops.
Avi Kapoor
PRO
Mangoceuticals Q4 EPS $(0.13) Up From $(1.01) YoY, Sales $94.360K Down From $105.247K YoY
Mangoceuticals (NASDAQ:MGRX) reported quarterly losses of $(0.13) per share. This is a 87.13 percent increase over losses of $(1.01) per share from the same period last year. The company reported $94.360 thousand in
Benzinga Newsdesk
Nasdaq Surges Over 1%; Lamb Weston Shares Decline Following Q2 Results
Avi Kapoor
PRO
Mangoceuticals Q2 EPS $(0.57) Up From $(1.35) YoY, Sales $168.109K Up From $163.163K YoY
Mangoceuticals (NASDAQ:MGRX) reported quarterly losses of $(0.57) per share. This is a 57.78 percent increase over losses of $(1.35) per share from the same period last year. The company reported $168.109 thousand in
Benzinga Newsdesk
PRO
Mangoceuticals On Aug. 14 Reported Quarter Ended June 30 EPS $(0.09) Up From $(0.14) YoY; Revenue $163,163 Up From $141,237 YoY
Benzinga Newsdesk
